Michelle Lose
Psychiatric/Mental Health · Louisville, KYNPI 1649848722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 490 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 490 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch Health US, LLC$1K
- AbbVie$942
- Supernus Pharmaceuticals, Inc.$727
- Otsuka America Pharmaceutical, Inc.$651
- Lundbeck LLC$529
- Neos Therapeutics, LP$420
- plus $3K from 17 others
What the payments were for
- Food & beverage$7,089100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch Health US, LLC | 89 | $1,054 |
| AbbVie | 83 | $942 |
| Supernus Pharmaceuticals, Inc. | 84 | $727 |
| Otsuka America Pharmaceutical, Inc. | 38 | $651 |
| Lundbeck LLC | 24 | $529 |
| Neos Therapeutics, LP | 33 | $420 |
| Vanda Pharmaceuticals Inc. | 14 | $401 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $362 |
| Alkermes, Inc. | 18 | $345 |
| Corium, LLC | 23 | $336 |
| Ironshore Pharmaceuticals Inc. | 11 | $241 |
| Johnson & Johnson | 11 | $190 |
| Tris Pharma Inc | 10 | $176 |
| Axsome Therapeutics, Inc. | 8 | $158 |
| Noven Therapeutics, LLC | 7 | $128 |
| Teva Pharmaceuticals USA, Inc. | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Almatica Pharma LLC | 4 | $71 |
| Idorsia Pharmaceuticals US Inc | 5 | $67 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Adzenys XR-ODT$144
- Cotempla XR-ODT$144
- Karbinal$144
- CAPLYTA$125
How this compares
$7,095 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 18 | $352 |
| Duloxetine Hcl | 12 | $192 |
| Gabapentin | 19 | $168 |
| Alprazolam | 43 | $133 |
| Quetiapine Fumarate | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Louisville
- Denise de AngelisLouisville$384K
- Mark BushLouisville$52K
- Harold O'BrienLouisville$28K
- Shane WattsLouisville$13K
- Clinton RayhillLouisville$9K
- Ryan HopsonLouisville$7K
- Kimberly ViltLouisville$7K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Jennifer SampangCrestview Hills$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.